Parallax Volatility Advisers
NKGNW

Parallax Volatility Advisers’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Parallax Volatility Advisers’s Portfolio NKGNW Stock Details NKGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-26,329
Closed -$7K – 3450
2022
Q2 		$7K Buy
+26,329
New +$10.4K ﹤0.01% 2706

Other funds holding NKGNW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
DCM
Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Parallax Volatility Advisers's NKGNW Position: Q3 2022 in Review

Parallax Volatility Advisers sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q3 2022, closing a stake of 26,329 shares — an estimated $7K sold.

Parallax Volatility Advisers first reported a position in NKGNW in Q2 2022 and held it in 1 quarter. The position peaked at $7K in Q2 2022. 32 funds tracked by Wall St. Rank hold NKGNW as of Q3 2022.

  • Parallax Volatility Advisers reported no remaining NKGen Biotech, Inc. Warrants position as of Q3 2022 after selling out during the quarter.
  • Parallax Volatility Advisers sold 26,329 NKGen Biotech, Inc. Warrants shares in Q3 2022, an estimated $7K.
  • Parallax Volatility Advisers first reported a position in NKGen Biotech, Inc. Warrants in Q2 2022 and held it in 1 quarter.
  • Parallax Volatility Advisers's NKGen Biotech, Inc. Warrants position peaked at $7K in Q2 2022.
  • 32 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q3 2022.

Based on Parallax Volatility Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.